AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

BATM Advanced Communications Ltd.

Regulatory Filings Feb 3, 2022

6682_rns_2022-02-03_b485c16c-aff9-4ae6-ae8a-c6735834a099.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 6305A

BATM Advanced Communications Ld

03 February 2022

LEI: 213800FLQUB9J289RU66

3 February 2022

BATM Advanced Communications Limited

("BATM" or "the Group")

Clarification on FTSE Nationality Review

Further to the Group's announcement earlier today, BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, confirms and clarifies that the Group will continue to be traded on both the London Stock Exchange and the Tel Aviv Stock Exchange ("TASE"). BATM's shares will continue to be listed on the Premium segment of the Main Market of the London Stock Exchange plc, notwithstanding this Index re-classification. 

Due to the Group's domicile in Israel, its dual listing on TASE and the volume of trading on that exchange, under the FTSE Russell Index rules, BATM, from the 21 March 2022, will, in all likelihood, no longer be eligible for inclusion in the FTSE UK Index Series (such as the FTSE All-share), but this does not affect the trading of the stock on either the London Stock Exchange or TASE, including all the indexes in TASE. Investors will continue to be able to trade BATM's shares as previously.

Enquiries:

BATM Advanced Communications
Dr Zvi Marom, Chief Executive Officer +972 9866 2525
Moti Nagar, Chief Financial Officer
Shore Capital
Mark Percy, Anita Ghanekar, James Thomas (Corporate Advisory) +44 20 7408 4050
Luther Pendragon
Harry Chathli, Claire Norbury +44 20 7618 9100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCUPUPPPUPPGGW

Talk to a Data Expert

Have a question? We'll get back to you promptly.